Loss of STAG2 function in Ewing sarcoma cells alters chromatin architecture and, in combination with the disruption of PRC2, activates an oncogenic developmental program to promote migration and metastasis [59, 76]. This evidence concerns the gene STAG2 and Ewing sarcoma.